These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22415341)

  • 1. Assessment of cognitive status in pediatric anti-NMDA receptor encephalitis during inpatient rehabilitation: A retrospective cohort.
    Howarth R; Blackwell L; Gombolay G
    J Neuroimmunol; 2023 Mar; 376():578048. PubMed ID: 36774765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very Long-Term Functional Outcomes and Dependency in Children With Anti-NMDA Receptor Encephalitis.
    Chen LW; Olivé-Cirera G; Fonseca EG; Mistieri Simabukuro M; Iizuka T; Armangue T; Dalmau J;
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200235. PubMed ID: 38621190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease course and psychosocial outcome for children and adolescents with anti-N-methyl-D-aspartate receptor encephalitis.
    Depreitere J; Antrop I; Verhelst H
    Clin Child Psychol Psychiatry; 2024 Apr; 29(2):648-660. PubMed ID: 37915202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pediatric Case of Anti-N-methyl-D-aspartate Receptor Encephalitis Associated With Optic Neuritis.
    You JY; Lacroix C; Toffoli D
    J Neuroophthalmol; 2022 Mar; 42(1):e289-e292. PubMed ID: 34001743
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to "Management of Anti- N-Methyl-d-Aspartate (NMDA) Receptor Encephalitis in Children".
    Brenton JN
    J Child Neurol; 2017 Jan; ():883073817689648. PubMed ID: 28112010
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review.
    Tarantino S; Averna R; Ruscitto C; Ursitti F; Ferilli MAN; Moavero R; Papetti L; Proietti Checchi M; Sforza G; Balestri M; Grimaldi Capitello T; Vigevano F; Vicari S; Valeriani M
    Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood Onset of Anti-N-Methyl-D-Aspartate Receptor Encephalitis Without Teratoma Masquerading as a Psychotic Disorder.
    Yeum TS; Lee J; Park SY; Joen Y; Kim BN
    Soa Chongsonyon Chongsin Uihak; 2019 Jul; 30(3):127-131. PubMed ID: 32595331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Anti-
    Remy KE; Custer JW; Cappell J; Foster CB; Garber NA; Walker LK; Simon L; Bagdure D
    Front Pediatr; 2017; 5():250. PubMed ID: 29226117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.
    Liu CY; Zhu J; Zheng XY; Ma C; Wang X
    Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and Challenges.
    Khair AM
    Neurol Res Int; 2016; 2016():7685807. PubMed ID: 27239341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehabilitation for a child with recalcitrant anti-N-methyl-d-aspartate receptor encephalitis: case report and literature review.
    Guo YH; Kuan TS; Hsieh PC; Lien WC; Chang CK; Lin YC
    Neuropsychiatr Dis Treat; 2014; 10():2263-7. PubMed ID: 25473290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges.
    Mann AP; Grebenciucova E; Lukas RV
    Ther Clin Risk Manag; 2014; 10():517-25. PubMed ID: 25061311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional status of children with encephalitis in an inpatient rehabilitation setting: a case series.
    Tailor YI; Suskauer SJ; Sepeta LN; Ewen JB; Dematt EJ; Trovato MK; Salorio CF; Slomine BS
    J Pediatr Rehabil Med; 2013; 6(3):163-73. PubMed ID: 24240837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune encephalitis in children.
    Armangue T; Petit-Pedrol M; Dalmau J
    J Child Neurol; 2012 Nov; 27(11):1460-9. PubMed ID: 22935553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rehabilitation of children with anti-N-methyl-D-aspartate-receptor encephalitis: a case series.
    Houtrow AJ; Bhandal M; Pratini NR; Davidson L; Neufeld JA
    Am J Phys Med Rehabil; 2012 May; 91(5):435-41. PubMed ID: 22415341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Functional Outcomes for Pediatric Patients Diagnosed with Anti-N-Methyl-D-Aspartate Receptor Encephalitis during Inpatient Rehabilitation.
    Howarth RA; Vova J; Blackwell LS
    Am J Phys Med Rehabil; 2019 Jul; 98(7):529-535. PubMed ID: 30379652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series.
    Goenka A; Jain V; Nariai H; Spiro A; Steinschneider M
    Pediatr Neurol; 2017 Jul; 72():51-55. PubMed ID: 28506503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Treatment and Early Rehabilitation Outcomes in Pediatric Patients With Anti-NMDA Receptor Encephalitis.
    Alvarez G; Krentzel A; Vova J; Blackwell L; Howarth R
    Arch Phys Med Rehabil; 2021 Mar; 102(3):406-412. PubMed ID: 33058859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis.
    DeSena AD; Greenberg BM; Graves D
    Pediatr Neurol; 2014 Oct; 51(4):542-9. PubMed ID: 25070939
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.